Navigation Links
Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
Date:11/7/2010

RESEARCH TRIANGLE PARK, N.C., Nov. 7, 2010 /PRNewswire-FirstCall/ -- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today reaffirmed its commitment to the dual development of CMX001 as a medical countermeasure against smallpox and as a broad-spectrum antiviral agent.  This statement follows notification from the Small Business Administration (SBA) that it has determined that SIGA Technologies, Inc. is not a small business, thus rendering SIGA ineligible for award of a government contract from the Biomedical Advanced Research and Development Authority (BARDA) that was designated as a small business set-aside.  

"Chimerix is deeply committed to developing and advancing safe, effective medicines that benefit public health.  We support the efforts of the Department of Health and Human Services to ensure that the government's requirement for smallpox therapeutics is met expeditiously and in accordance with Federal Acquisition Regulations," stated Kenneth I. Moch, President and Chief Executive Officer of Chimerix.  

"The most important advancement we have made in the clinical and preclinical development of our lead antiviral candidate, CMX001, is to establish its profile as a broad-spectrum therapeutic with the potential to treat a number of fatal diseases.  Our clinical experience with patients to date keeps us extremely motivated to see its development through registration and approval. Combined with its potential to address the smallpox threat, we feel CMX001 is well positioned to address the broadest definition of unmet medical need," said Wendy Painter, M.D., M.P.H., Chief Medical Officer of Chimerix.

CMX001 – An Antiviral with Broad-Spectrum Activity

CMX001 is in advanced development as a medical countermeasure for the treatment of smallpox.  CMX001 has demonstrated protection from mortality in animal models of human smallpox disease in multiple pr
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Chimerix to Present at 9th Annual BIO Investor Forum
2. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
3. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix to Present at Two Upcoming Investor Conferences
6. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
7. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
8. CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance
9. Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
10. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
11. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Calif., July 31, 2014 Pharmacyclics, Inc. (the "Company") ... recent developments for the quarter ended June 30, 2014. ... June 30, 2014 Revenue Total revenue for the quarter ... million for the quarter ended June 30, 2013 primarily due ... million. Total revenue for the six months ...
(Date:7/31/2014)... 31, 2014  UBM Medica US announces that ... for oncologists, presents exclusive slide shows dealing with communication ... quality cancer care. Cancer Network, ... offers news, blogs, and podcasts about the latest clinical ... care: , End-of-life care is challenging for ...
(Date:7/31/2014)... , July 31, 2014 Touro University ... has been selected as the recipient of a $150,000 ... will allow the University to increase research and classroom ... creating state-of-the-art technology for the study of health sciences, ... the diverse needs and interests of our students," said ...
Breaking Medicine Technology:Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24Pharmacyclics Reports Second Quarter 2014 Results 25Pharmacyclics Reports Second Quarter 2014 Results 26Pharmacyclics Reports Second Quarter 2014 Results 27Pharmacyclics Reports Second Quarter 2014 Results 28Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Touro University California Garners Grant From Long Foundation 2
... Tool Detects Risk for Undiagnosed Diabetes, Plus: ... ALEXANDRIA, Va., April 28 A highly detailed,mathematical ... whether they likely have the disease and can ... associated with this now,epidemic illness, according to studies ...
... Fighting Blindness ... OWINGS MILLS, Md., April 27 Scientists employing a ... blind from,a condition known as Leber congenital amaurosis (LCA) -- ... trial, which was,funded in part by the Foundation Fighting Blindness, ...
Cached Medicine Technology:Drug Combo Could Lower Diabetes Complications and Costs 2Drug Combo Could Lower Diabetes Complications and Costs 3Drug Combo Could Lower Diabetes Complications and Costs 4Drug Combo Could Lower Diabetes Complications and Costs 5Gene Therapy Provides Vision to People who Were Nearly Blind 2
(Date:8/1/2014)... (GSA) the nation,s largest interdisciplinary organization devoted to ... Lewis, PT, DPT, PhD, GTC, GCS, MSG, MPA, FAPTA, ... of Aging Persons Award. , This distinguished honor is ... of rehabilitation. The awardee,s work may be in the ... may include scholarly works, books, monographs, administrative directives, or ...
(Date:8/1/2014)... According to Forrester Research, more than 90 percent of ... of information, and thanks to the launching of DCInsurers Agent ... resources on insurance specifically for the state of Colorado can ... step in the growth of our business,” Doug King, owner/agent ... Insurance Resources office. “We recognize that the web is how ...
(Date:8/1/2014)... August 01, 2014 Frontier Nursing University ... and Services Administration’s Advanced Education Nursing Traineeship (AENT) ... provide direct support to 280 students over the grant ... Program is to increase the number of advanced education ... nursing faculty to address the nurse faculty shortage that ...
(Date:8/1/2014)... Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) ... the first molecular test kit that can predict ... This breakthrough was recently reported in European ... , According to IBN Executive Director Professor Jackie ... diagnostics and cancer research, we have developed the ...
(Date:8/1/2014)... August 01, 2014 St. Christopher's Hospital ... an upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , St. Christopher's Hospital for ... for children from birth through 21 years of age. ... of the hospital's specialties, including autism and childhood obesity. ...
Breaking Medicine News(10 mins):Health News:Lewis to receive GSA's 2014 Excellence in Rehabilitation of Aging Persons Award 2Health News:DCInsurers Agent Doug King Launches a New Website 2Health News:DCInsurers Agent Doug King Launches a New Website 3Health News:Frontier Nursing University Receives $700,000 in Scholarships for Advanced Practice Nursing and Midwifery Students 2Health News:Taking the guesswork out of cancer therapy 2Health News:Taking the guesswork out of cancer therapy 3Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 2Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 3
... Facilities Treated with the Antimicrobial Protection of the ... SportsAide(R) System from SportCoatings(TM), EAST ... are,the next team in the NBA scoring with the ... antimicrobial contamination. SportsAide is part of the Sports ...
... Meeting Expectations today announced,that it has been named ... the industry,s,largest and most influential full-service independent meeting ... market. Compiled by,Penton Media,s Corporate Meetings & Incentives(R) ... corporate meetings and events,industry, the CMI 25 provides ...
... putting patients with heart disease at risk by affecting blood ... the University of Edinburgh and Ume University measured the effects ... men who have previously experienced a heart attack. , ... in the New England Journal of Medicine, found that inhalation ...
... showed effect after brief exposure to diesel exhaust , , ... not to take your daily jog during rush ... exposed, even briefly, to diesel exhaust fumes showed reduced blood ... various cardiovascular problems, including heart attacks and arrhythmias. , The ...
... Sept. 12 Having already made great,strides in ... is,ready to take on America. Terumo Interventional ... Coronary Guidewire to the U.S. market. With its ... this,coronary guidewire boasts efficiency and reliability unlike that ...
... Alliance,for Hispanic Health (the Alliance) is launching a ... (Presion alta...El control,esta en tus manos) with the ... promoting prevention, and helping Hispanic adults bring,their high ... and blood pressure screening events in San Antonio ...
Cached Medicine News:Health News:New Jersey Nets Shoot Down Staph with High-Tech Defense 2Health News:Meeting Expectations Named to First Annual 'CMI 25' List by Corporate Meetings & Incentives Magazine 2Health News:Diesel exhaust may increase risk in patients with heart disease 2Health News:Jogging in Traffic Cuts Blood Flow to Heart 2Health News:Jogging in Traffic Cuts Blood Flow to Heart 3Health News:Proven Terumo Coronary Guidewire Technology Is Now Available in the United States 2Health News:Proven Terumo Coronary Guidewire Technology Is Now Available in the United States 3Health News:Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio 2Health News:Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: